Daniel Siegel, M.D.
Daniel M. Siegel, MD, is a Clinical Professor of Dermatology and former Director of the Procedural Dermatology Fellowship at SUNY Downstate. He has served as a president of the AAD (2012) and is a past member of both the Academy’s board of directors and Coding and Reimbursement Task Force. He is a diplomate of the American Board of Dermatology and the American Board of Laser Surgery and is a fellow of the American Society for Dermatologic Surgery (ASDS), the American Academy of Dermatology (AAD), the American College of Mohs Surgery and the American Society of Mohs Surgery. Dr. Siegel earned his medical degree from Albany Medical College in Albany, N.Y. He completed his residency in dermatology at the University of Texas Health Sciences Center at Dallas and his fellowship at the Baylor College of Medicine in Houston. Dr. Siegel also earned a Master of Science degree in management and policy from Stony Brook University, Stony Brook, N.Y.
Laura Ferris, M.D., Ph.D.
Laura Korb Ferris, MD, PhD is an Associate Professor and Director of Clinical Trials at the University of Pittsburgh Department of Dermatology. She is a member of the University of Pittsburgh Cancer Institute melanoma program where directs the pigmented lesions clinic. Dr. Ferris has been an investigator on several clinical trials evaluating technologies and assays for melanoma early detection and predictors of outcome in patients with melanoma. Her research, which is primarily focused on melanoma epidemiology, screening, and early detection has been widely published in the peer-reviewed literature. Dr. Ferris received her PhD in immunology from The Johns Hopkins School of Medicine and her MD from The University of Maryland and she completed her residency in dermatology and fellowship in cutaneous oncology at the University of Pittsburgh.
Ronald Moy, M.D.
Ronald Moy, M.D. is a Board Certified Dermatologist and a diplomate of the American Board of Dermatology. He is a leader in the field of dermatology as a past President of the American Academy of Dermatology, Pacific Dermatologic Association and American Society for Dermatologic Surgery and as Vice President of the Skin Cancer Foundation. Dr. Moy completed his dermatology residency training at UCLA and his Facial Cosmetic and Mohs Micrographic Surgery Fellowship training at the University of Pittsburgh Center for Health Services. He is a former professor at the David Geffen School of Medicine at UCLA, former Co-Chief of the UCLA division of Dermatology and former Chief of Dermatologic Surgery. He has served as president of the Los Angeles County Medical Association, Bay District and Editor-in-Chief of the Dermatologic Surgery Journal.
Darrel Rigel, M.D.
Darrel Rigel, MD is a Clinical Professor of Dermatology at New York University Medical Center. He received his BS and MBA from MIT and his MD degree from George Washington University. He attended Cornell University Medical Center for his Internship in Internal Medicine, and completed his training at NYU where he was Resident, Chief Resident, NIH Training Fellow and Dermatology Surgery Fellow. Dr. Rigel has served as President of the American Academy of Dermatology (1999) and for 9 years as a Director of the American Board of Dermatology. He is a Past President of the American Society for Dermatologic Surgery and the American Dermatological Association. Dr. Rigel has also received numerous honors including the American Cancer Society’s National Honor Citation for Skin Cancer Programs and Presidential Citations from the American Academy of Dermatology and American Society for Dermatologic Surgery for public education programs in skin cancer.
Abby Van Voorhees, M.D.
Dr. Van Voorhees, M.D., is a Professor and Chair of Dermatology at East Virginia Medical School and a past Director of Psoriasis Services and Phototherapy Units at the University of Pennsylvania. Dr. Van Voorhees received her MD from Yale University and attended Temple University for her Internship. Her residency training was completed at Yale. Dr. Van Voorhees is the Medical Editor of Dermatology World, the official magazine of the American Academy of Dermatology and Chair of the National Psoriasis Foundation (NPF) medical board.
Stevan Knezevich, M.D.
Stevan Knezevich is Board Certified in Dermatopathology, Anatomic Pathology, and Clinical Pathology. He received his MD from the University of Toronto Medical School. Prior to this, he received his PhD in Pathology from the University of British Columbia and spent an additional year as a post-doctoral fellow in Lymphoma research. His Residency and Surgical Pathology Fellowship were completed at Washington University in St. Louis, MO and his Dermatopathology Fellowship at Stanford University. Dr. Knezevich worked at the VA Medical Center and served as Assistant Professor at the University of Washington in Seattle.
Gerald Krueger, M.D.
Gerald G Krueger, MD is Professor of Dermatology and Edna Benning Presidential Endowed Chair at the University of Utah in Salt Lake City, UT. He received his medical degree from Loma Linda University in Loma Linda, CA, and completed his residency in dermatology at the University of Colorado. Dr. Krueger is the recipient of the Taub International Award for Psoriasis Research and a National Psoriasis Foundation Lifetime Achievement Award. Dr. Krueger is a world-renowned expert in the area of psoriasis and was awarded the 2016 Presidential Citation for Psoriasis Research by the American Academy of Dermatology. His research interests involve the study of new agents targeting pathways that lead to psoriasis and the discovery of genes that lead to various forms of psoriasis. His work has published in several leading peer-reviewed journals including Nature Genetics, and the New England Journal of Medicine. He currently serves as Chairman Emeritus on the Medical Board of the National Psoriasis Foundation.
Pedram Gerami, M.D.
Pedram Gerami, MD is an associate professor of dermatology and pediatrics at Northwestern University and the co-director of melanoma research at the Northwestern Skin Cancer Institute. Dr Gerami is interested in the clinical, histologic and molecular genetics of melanocytic neoplasms. As a clinical dermatologist he sees patients with a history of melanoma or dysplastic nevi and as a dermatopathologist he is focused in the histopathologic evaluation of melanocytic neoplasms. He has authored over 80 peer reviewed journal articles and numerous chapters in dermatologic textbooks. His research is primarily focused on the use of molecular diagnostics to improve diagnosis and prognostication of melanocytic neoplasms. Dr Gerami received his medical degree from the Chicago Medical School and received his residency at the University of Iowa Department of Dermatology followed by a fellowship in dermatopathology at the University of Chicago.